Articles

A digital revolution for patient care

22nd July 2014

A digital revolution for patient careSunil Rao

The digital maturity of life sciences companies will change significantly in the next three years as digital technology yields a wealth of data that provides opportunities to drive more innovation,... Read more

CCGs – the story behind the headlines and implications for market rese…

21st July 2014

CCGs – the story behind the headlines and implications for market researchJudy Norcross

Why the recruitment, screening and sampling process needs to work harder in market research to understand the needs, behaviours, priorities, and attitudes in CCGs.The NHS reforms introduced in 2013 were... Read more

Time and Motion Studies: Opportunities and Challenges

18th July 2014

Time and Motion Studies: Opportunities and ChallengesErwin De Cock and Karen Yeomans

Time and motion studies can be a useful way to gather real world evidence of a medical intervention's value.When the efficiency of a drug, medical device, or intervention is the... Read more

Achieving market access in the UK with a little help from Patient Acce…

17th July 2014

Achieving market access in the UK with a little help from Patient Access Schemes Leela Barham

Gaining access to the UK market is increasingly about achieving a 'yes' from NICE. And for over 40 products, having a Patient Access Scheme (PAS) in place has helped companies... Read more

News

Allergan cuts workforce as part of restructure

22nd July 2014

Allergan cuts workforce as part of restructureLinda Banks

Allergan has announced that about 13 per cent of its workforce will go as part of a restructure in the second half of 2014.About 1,500 employees – a higher number... Read more

Pharma companies offer up compounds to UK researchers

22nd July 2014

Pharma companies offer up compounds to UK researchersAndrew McConaghie

Seven pharmaceutical companies have agreed to grant UK academic researchers access to a virtual library of 'deprioritised' compounds.The partnership is between the Medical Research Council (MRC) and AstraZeneca, GlaxoSmithKline, Janssen... Read more

HIV community mourns lost colleagues

22nd July 2014

HIV community mourns lost colleaguesStaff reporter

The start of the International Aids Conference in Melbourne this week has been overshadowed by the tragic deaths of six delegates who were on board Malaysia Airlines MH17.Tributes have poured... Read more

Pharma's fixation on amyloid misguided, says TauRx chair

21st July 2014

Pharma's fixation on amyloid misguided, says TauRx chairStaff Reporter

The pharma industry's dogged determination to develop amyloid-targeting therapies for Alzheimer's disease is a "road to nowhere", according to the scientist behind a rival approach.Claude Wischik, professor of old age... Read more

Audio & Video

Webinar: 9 July - The future of UK pharm…

WEBINAR COVER smaller


The global pharmaceutical market passes a significant milestone in 2014: reaching one trillion US dollars in total value. IMS Health... View more

Rare Disease Day tweetchat

 

To view a full transcript of the discussion from this #hcsmeu tweetchat held on 28th February 2014 please click View more

Is there common ground for engagement be…

Doctors net webinar

 

The growth of online networks for doctors has been accompanied by recognition from the pharmaceutical industry that these digital meeting grounds can be... View more

Executive Perspectives: Jane Griffiths

 

In the latest in our series of interviews with senior executives who are steering the global pharma industry through a period of unparalleled change, pharmaphorum... View more

White Papers

Diabetes in Germany

Diabetes in GermanyJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Connected data and the use of smartphone…

Connected data and the use of smartphone enabled apps in market researchPaul Mannu

Rapid growth in smartphone usage offers healthcare researchers a useful tool to gain better understanding of how patients and healthcare professionals actually behave on a daily basis. Inaccuracies can arise... View info

Diabetes in the UK

Diabetes in the UKJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Is pharma brand marketing dead or has it…

Is pharma brand marketing dead or has it just arrived?Mark Sales and Fabrice Bourg

As the pharma industry scrutinizes every aspect of its operations in the drive for greater efficiency, the processes behind marketing have so far seen little impact. But now, with fewer... View info

Further News & Articles

AbbVie and Shire merger agreed

AbbVie and Shire have announced that their long-awaited merger is to go ahead, following AbbVie's f... Read more

News

AstraZeneca unveils plans for Cambridge headquarters

AstraZeneca has revealed the proposed designs for its new global R&D centre and corporate headquarters in... Read more

News

GSK's China crisis just won't go away

GlaxoSmithKline (GSK) said this week that it had fired some of its employees in China for corruption way back... Read more

News

Roche reports disappointing results for Alzheimer’s candidate

With limited results in Alzheimer's Disease (AD) for crenezumab from two phase II studies announced this week... Read more

News

Wales launches its own life sciences hub

A new initiative has been launched to help the life sciences sector flourish in Wales, with a £100 million in... Read more

News

Sterile injectables growth tempts Pfizer into $360m InnoPharma acquisition

Pfizer has increased its position in the $7 billion-plus market for sterile injectable drugs with a $360 mill... Read more

News